Guess we all have different investment plans & strategies as the PAA story plays out over the next 18 months - 2 years.
Important thing is to plan !
For me, it goes something like this ( until the plan changes of course ! ).
1. News on MPL MoA and possible efficacy against other neurodegenerative conditions, plus Healey first recruitment ( and all the preceding news to this milestone ) should see the company approach a $500M MC, perhaps an initial sign-on deal from a mid-size / big Phrama. So, around $1.00 SP. I'll be taking around 20% off the table at this stage - enough for free carry and to invest in some other life pursuits.
2. The remainder - while the science remains compelling, I'd like to see it through to Healey results come in. If they are as positive as very early indications suggest - well then a $2.5B - $5.0B MC may well be representative of true value.
In the meantime, SP machinations remain background noise.
ALL IMO.
Definitely not financial advice
Pharmaust - Media & News, page-171
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.42M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.3¢ | 19.0¢ | $25.41K | 133.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5372 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 262575 | 3 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |